Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Ganitumab |
Trade Name | |
Synonyms | AMG-479 |
Drug Descriptions |
Ganitumab (AMG-479) is a recombinant antibody that binds to and inhibits IGF-1R. Inhibition of IGF-1R prevents activation of the downstream PI3K/Akt pathway, which may inhibit proliferation and induce apoptosis of tumor cells (NCI Drug Dictionary). |
DrugClasses | IGF-1R Inhibitor 17 |
CAS Registry Number | 905703-97-1 |
NCIT ID | C71531 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Alpelisib + Ganitumab | Alpelisib Ganitumab | 0 | 1 |
Binimetinib + Ganitumab | Binimetinib Ganitumab | 0 | 1 |
Conatumumab + Ganitumab | Conatumumab Ganitumab | 0 | 0 |
Dasatinib + Ganitumab | Dasatinib Ganitumab | 0 | 1 |
Everolimus + Ganitumab | Everolimus Ganitumab | 0 | 1 |
Everolimus + Ganitumab + Panitumumab | Everolimus Ganitumab Panitumumab | 0 | 1 |
Ganitumab | Ganitumab | 0 | 3 |
Ganitumab + Palbociclib | Ganitumab Palbociclib | 0 | 1 |
Ganitumab + Trametinib | Ganitumab Trametinib | 7 | 0 |